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1705-41 Idiopathic Right Ventricular Outflow Tract
Tachycardia: Narrowing the Anatomic Location for
Successful Ablation
Colin Movsowitz, Charles D. Gottlieb, David J. Callans, Josephine R. Saligan,
Volker Menz, David Schwartzman, Erica Zado, Francis E. Marchlinskl. Phdadelphia
Heart Institute, Philadelphia, PA
Pace-mapping is the primary technique used to localize the origin of ven-
tricular tachycardia (VT) from the right ventricular outflow tract (RVOT). We
previously divided the RVOT septum into 9 equal sites Isee figure) and devel-
oped a surface ECG algorithm for identifying the 9 paced sites based on the
orientation of the QRS complex in leads I and aVL and the precordial R wave
progression. Based on this algorithm and initial experience with catheter ab-
lation of RVOT-VT, we hypothesized that most RVOT-VTs originate from a
limited area in the RVOT. corresponding to the mid to anterior and superior
RVOT septum just below the pulmonic valve (sites 2 & 3). To test this hy-
pothesis, we documented fluoroscopically the site of identical pace-maps
and successful radiofrequency (RF) catheter ablation of RVOT-VT in 14 con-
secutive patients (12 female; ages 23-66 years). All patients presented with
palpitations and/or presyncope and left bundle branch blocklinferior VT with
a right (n = 5) or left (n = 91 axis. Each patient had a structurally normal heart
A lesion was considered successful if no tachycardia could be induced with
atrial or ventricular pacing (± isopreterenol) after having been reproducibly
initiated prior to lesion application. Result: In each patient. the site of best
pace-map and successful ablation was site 2 or 3 (The figure represents a
right anterior oblique view of the right ventricle:
Conclusion: In most patients with RVOT-VT, the site of successful RF
catheter ablation was in the mid to anterior and most superior aspect of
the RVOT septum. These findings may simplify the approach to RF catheter
ablation of RVOT-VT and thus decrease fluoroscopic exposure in these pa-
tients.
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1705-51 Comparison of Radiofrequency Lesions in the
Canine Left Ventricle Using a Saline Irrigated
Electrode Versus Temperature Control
Hiroshi Nakagawa, William S. Yamanashi, Jan V. Pitha, Khek C. Yong,
Mauricio Arruda, Michael Rome, Xanzhang Wang, Ken-ichlro Ohtomo,
Ralph Lazzara, Warren M. Jackman. University of Oklahoma, Oklahoma City. OK;
DVAMC, Oklahoma City. OK
The maximum power deliverable by present radiofrequency (RF) ablation
systems is limited by an impedance rise which occurs when the tempera-
ture at the electrode-tissue interface reaches 100'C. The limitation in power
limits the depth and diameter of the lesion. The present method to avoid
an impedance rise and maximize power delivery utilizes a thermistor in the
ablation electrode. The power is varied to maintain a target temperature
and prevent the temperature from exceeding 90-95'C (temperature control
approach-TC). An alternative approach utilizes saline irrigation of the abla-
tion electrode (active cooling) to prevent an impedance rise at high power
(IR approach). The purpose of this study was to compare LV lesion size pro-
duced by the IR and TC approaches. In 15 anesthetized dogs (18-22 kg), a 7F
deflectable catheter with a lumen and 5 mm tip electrode containing a ther-
mistor and 6 Irrigation holes (located radially, 1 mm from tip) was inserted
into a carotid artery and advanced to the LV under fluoroscopic guidance.
RF current was applied at one site by manually controlling voltage (30-80 V)
to maintain the electrode temperature at 80-90'C (TC) and at a second site
using saline irrigation (60 mllmin) and constant voltage of 90V (IR). In 3 addi-
tional dogs with remote myocardial infarction (3--6 months), a total of 4 RF
lesions was made at the border of the scar, all by IR approach (fR MI). The
15 dogs were sacrificed 6 days after ablation and the 3 dogs with infarction
were sacrificed 4 hours after ablation.
Results:
Voltage Power Imp Rise Elect temp Lesion Depth Diameter
(VI (WI 1°C) (mm)
TC 15 57 ± 13 36 ± 17 3/15 84 ± 3 9.3 ± 20 12.7 ± 2.4
IR 15 90 ± O' 88 ± 8' 6/15 38± 4' 12.1 ± 2.4' 20.5 ± 2.8*
IRMI 4 90 ± 0 81 ± 10 3/4 36 ± 3 8.6 ± 1.0 16.0 ± 2.4
'p < 0.01; TC vs.IR
All impedance rises occurred after >30 seconds and with electrode tem-
perature <80°C and an audible pop, suggesting release of steam from below
the endocardial surface instead of boiling at the electrode-tissue interface.
Conclusions: 1) Electrode cooling by saline irrigation allows sustained RF
energy at high power; producing larger and deeper lesions in normal LV my-
ocardium; 2) the deeper lesions with a cooler electrode suggests direct re-
sistive heating occurs relatively far from the electrode; and 3) reasonable
lesions can be obtained in infarcted LV using irrigation.
11 :45
Post-Infarct Ventricular Tachycardia: Success Rate of
Catheter Ablation
Steven A. Rothman, Henry H. Hsia, Sergio F. Cossu, Lisa M. Thome, Nancy
M. Adelizzi, Deborah M. Whitley, Alfred E. Buxton, John M. Miller. Temple University
School of Medicine, Philadelphia, PA
Reports of catheter ablation (CA) of infarct-based ventricular tachycardia (VT)
have generally targeted slow VTs of 1 morphology; success rates have been
variable. We performed radiofrequency CA in 25 patients (pts) who pre-
sented with sustained uniform VT, with the intent of eliminating all inducible
uniform-morphology VTs (not just "clinical" VTs). CA was performed during
94 distinct VTs; 65 of these (69%) could not be induced thereafter. In individ-
ual pts, success of CA was defined as complete (absence of any inducible
uniform VT) or partial (elimination of some but not all VTs). Results among
the 25 pts:
Success #VTs/Pt Procedure Time (min) Recurrence
Complete 17168%1 3.0 ± 20' 320 ± 168 010%)
Partial 5(20%1 6.4 ± 4.0' 306 ± 175 5(100%}
Failure 3(12%) 3.7 ± 2.9 243 ± 119 1(33%)
P value 0.03' NS 0001
Of the 17 pts with complete success, 10 received no other treatment.
5 had an implantable defibrillator and 2 pts remained on prior antiarrhyth-
mic drugs. No clinical recurrences or implantable defibrillator discharges oc-
curred in any of these pts after a mean follow-up of 6 ± 4 months. Follow-up
stimulation 3 months later showed no inducible VT in 8/10 pts 180%) dis-
charged without inducible VT. Of the 5 pts with partial success, 3 have had a
marked decrease in frequency of VT recurrences. None of the documented
recurrences was fatal. One pt with frequent episodes of stable VT for years
had possible sudden death 2 months post CA (without symptoms in interim).
The mean cycle length of successfully ablated VTs was 366 ± 74 ms vs 312
± 51 ms for unsuccessfully ablated VTs (p < 0.01).
Conclusions: 1) Immediate and long term success can be achieved with
aggressive radiofrequency CA in a majority of patients with sustained
monomorphic VT post-infarct. even when multiple VT morphologies are
present. 2) VTs with cycle length <400 ms can be successfully ablated but
faster VTs are less easily ablated, not entirely related to hemodynamic toler-
ance.
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1706-1 I Preconditioning Ischemia Time Determines the
Degree of Glycogen Depletion and Infarct Size
Reduction in Rat Hearts
Vania Barbosa, Richard E. Sievers, Christopher L. Wolfe. University of California San
Francisco, San Francisco, CA
Infarct size reduction after ischemic preconditioning has been reported as
an all-or-nothing response, with a threshold of 2 to 5 min of preconditioning
ischemia time. Furthermore, infarct size reduction is associated with glyco-
gen depletion before prolonged ischemia. We sought to determine whether
increasing preconditioning ischemia time results in progressive myocardial
glycogen depletion and infarct size reduction and if so, whether I~farct size
reduction correlates with glycogen depletion before prolonged Ischemia.
Therefore, ventilated rats underwent a single episode of preconditioning is-
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chemia lasting 1.25 (n ~ 18), 2.5 (n = 20), 5 (n = 9), or 10 (n ~ 161 min, or
multiple episodes cumulating in 10 (2 x 5 min, n = 17) or 20 (4 x 5 min,
n = 13 or 2 x 10 min, n = 14) min of preconditioning ischemia time, all
followed by 5 min of reperfusion. Control rats (n ~ 22) were not precondi-
tioned. In separate groups, glycogen was determined before whereas infarct
size was determined after prolonged ischemia (45 min) and reperfusion (120
min). Myocardial glycogen levels and infarct size are shown as a function of
preconditioning ischemia time.
Protocol I, dogs received 45-min episodes of preconditioning ischemia (PC:
n = 7) or a comparable control period In ~ 9) before sustained CO; Proto-
col II was identical except polymyxin-B (PMX: 50 mg/kg) was administered
throughout the PC regimen (n = 6) or control period (n = 6). Blood flow to
the ischemic subendocardium was assessed during sustained CO by injec-
tion of ratJiolabeled microspheres, and area of necrosis (AN) was delineated
by tetrazolium staining and expressed as a % of the area at risk of infarction
(ARI.
PC G + PC AD G + AD CP G+ CP CG G + CG
t P:5 0.05: one-way ANOVA and SNK multiple range test
Endo Flow (mllminlg) ANIAR (%)
Protocol I: Control 006 ± 0.02 19 ± 3
PC 0.09 ± 003 6 ± 2"
Protocol II: Control + PMX 001 ± 001 29 ± 5
PC + PMX 0.02 ± 001 10 ± 3\
" p < 0.01 vs Control: \ p < 0.01 vs Control + PMX
Michel Ovize, Jean F Aupetlt, Gilles Rioufol, Joseph Loufoua, Xavier Andre-Foust,
Yves Minaire. Hopital Cardiologique, Lyon, France; University Claude Bernard, Lyon,
France
Preconditioning (PC) prevents ventricular fibrillation (VF) in the rat heart. We
sought to determine whether this protective effect might: (11 apply to the pig
heart, (2) be related to modifications of electrophysiologic parameters. Forty-
eight anesthetized pigs underwent 40 min of LAD coronary artery occlusion
(CO) followed by 2 hours of reperfusion (R) Prior to this, PC hearts received
10 min of CO and 10 min of R. Area at risk and infarct size were measured by
injection of blue dye and triphenyltetrazolium staining, respectively. Duration
of subepicardial monophasic action potential (MAPD) and VF threshold were
measured at different time points of the experiment. As expected, infarct
size was significantly reduced in PC hearts, averaging 6 ± 4%' of the risk
region versus 28 ± 4% in controls (* p < 0.01). But, incidence of VF was
not reduced in the PC group: 69% vs 63% in the control group (p = NSI.
Furthermore, time to VF during the 40 minute CO was significantly shorter
in PC than in control hearts: 7 ± 2 min' vs 18 ± 2 min 1* p < 0.01). This was
associated with a significantly lower VF threshold and shortening of MAPD
in PC hearts at the onset of the sustained CO. At 3 min of ischemia, VF
threshold averaged 2.3 ± 1.7 mAIO in PC vs 4.1 ± 2.4 mA in controls (* p
< 0.01 vs control). MAPD averaged 197 ± 4 ms' in PC hearts versus 214 ±
4 ms in controls 1* p < 0.05). This suggests that preconditioning does not
prevent but accelerates ventricular fibrillation in pig hearts via a decrease
of the fibrillation threshold and a shortening of monophasic action potential
during the first minutes of the sustained ischemia.
Protocol I confirmed the expected reduction in infarct size in precondi-
tioned dogs vs. controls. Protocol II revealed that all PMX-treated dogs were
rendered profoundly ischemic during CO. Nonetheless, treatment with PMX
did not attenuate the reduction in infarct size achieved with preconditioning.
Thus, the PKC inhibitor polymyxin-B may exacerbate ischemia during CO:
this may contribute to the previously reported "increase" in infarct size in
preconditioned rabbits treated with this agent. Polymyxin-B did not, however,
block the cardioprotective effects of preconditioning in this canine model.
11: 15
1706-41 Preconditioning Shortens Action Potential Duration
and Lowers Ventricular Fibrillation Threshold in Pig
Hearts
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In addition, infarct size reduction correlated with glycogen depletion be-
fore prolonged ischemia (r = 0.98; 19 P < 0.001). Thus, increasing precondi-
tioning ischemia time results in progressive myocardial glycogen depletion
and infarct size reduction, reaching a maximal effect when the precondition-
ing ischemia time is :0:5 min. This maximal effect may be due to marked
depletion of myocardial glycogen stores before prolonged ischemia.
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The anti-infarct effect of ischemic preconditioning (PC) is partly due to adeno-
sine receptor-mediated opening of KATP channels. PC-mediated protection
may be potentiated by exogenous infusion of adenosine receptor agonists.
To test this hypothesis, pentobarbital anesthetized rabbits (n = 8/group) un-
derwent two cycles of 5 min regional ischemia and 5 min coronary reperfu-
sion (REP; i.e., PC) followed by 30 min ischemia and 3 h REP Rabbits received
either adenosine (AD; 0.01 mg/min); cyclopentyladenosine (CP; Al recep-
tor agonist; 0.001 mg/minl or CGS 21680 (CG; A2 receptor agonist; 001
mg/min), i. v. for 65 min starting 5 min before onset of REP KATP channels
were blocked with i.v. glibenclamide (G; 0.15 mglkg) 10 min before PC in the
absence or presence of AD, CP or CG. Infarct and risk (R; cm3) volume was
assessed with tetrazolium and microsphere autoradiography. Infarct size (IS)
was normalized to R. IS in absolute controls (i.e., no PC) was 51 ± 6% (mean
±SEMI
R 1.6± 1 1.8±0.2 1.6±0.2 1.4±0.1 1.9±0.1 1.4±0.3 2.0±0.2 1.2±0.1
IS 19±2 39±7t 27±7 37±6t 12± 1 44±9t 22±3 50±5t
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1706-21 Adenosine-mediated Myocardial Protection During
Preconditioning is Abolished by KATP Channel
Blockade in Rabbits
John G. Kingma Jr., Mette Hazenberg, Denis Simard, Jacques R. Rouleau. Laval
University, Quebec, Canada
Cardiodynamics were similar for the treatment groups; but heart rate-
blood pressure product was lower (p ::: 0.05) during CP infusion. Conclu-
sions: 1) PC markedly reduced IS; 2) PC-mediated protection was not po-
tentiated with exogenous AD, CP or CG; and 3) G abolished PC-mediated
protection withouVwith exogenous AD, CP or CG. These data indicate that
adenosine receptor activation and opening of KATP channels are involved in
Pc.
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The Protein Kinase C Inhibitor Polymyxin-B does not
Block Preconditioning-induced Cardioprotection in
the Canine Model
Karin Przyklenk, Robert A. Kloner. Heart Institute, Hospital of the Good Samaritan, Los
Angeles, CA; University ofSouthern California, Los Angeles, CA
In the rabbit model, administration of protein kinase C IPKCI inhibitors such
as polymyxin-B have been reported to attenuate the reduction in infarct size
achieved with ischemic preconditioning. Activation of PKC has therefore
been proposed to playa crucial role in the mechanism by which precon-
ditioning protects the heart from subsequent sustained coronary occlusion
(CO). However, the possible confounding effects of PKC inhibition on my-
ocardial blood flow were not assessed in these studies. We addressed this
issue in 28 dogs subjected to 1 h of sustained CO and 4-5 h of reperfusion. In
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1706-51 Calcitonin Gene-related Peptide Improves Recovery
from Reversible Myocardial Ischemia
Ravi N. Samy, Scott C. Silvestry, B. Zane Atkins, James W. Davis, R. Eric Lilly, David
C. Sabiston, Jr., Donald D. Glower. Duke University, Durham, NC
Calcitonin gene-related peptide (CGRP) has been found to have inotropic
properties and a short half-life. CGRP has been demonstrated to reduce is-
chemic injury in tissue flaps as well as to increase coronary artery flow, while
other available inotropes have been shown to impair recovery from myocar-
dial ischemia. Yet, a therapeutic role for CGRP in myocardial ischemia has
not been defined. Therefore, CGRP was compared to placebo in nine chron-
ically instrumented conscious dogs who underwent two 15 minute left an-
terior descending coronary artery occlusions separated by at least 24 hours
of reperfusion. Left ventricular transmural pressure and myocardial segment
length were measured at control and during reperfusion. Either CGRP (0.07
Ilg/kglmin) or saline placebo was randomly chosen and continuously infused
from 45 to 105 minutes of reperfusion. The alternative infusion was given
during the second study. Regional function was assessed using preload re-
cruitable work area (PRWA), a load-insensitive measure of regional myocar-
dial performance. PRWA was calculated as the area beneath the linear stroke
work vs. end-diastolic length relationship. Data are mean PRWA (% of con-
